PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients
PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients
Recruiting · NCT05440227 · Registry updated 2025-06-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients | Fatigue, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2025-06-05 | NCT05440227 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| PhytoHealth Corporation | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Taiwan University Hospital | Taipei | Taiwan | 203 |